Management of Anaphylaxis
Immediately administer intramuscular epinephrine 0.01 mg/kg (maximum 0.3 mg in prepubertal children, 0.5 mg in adults) into the mid-outer thigh as soon as anaphylaxis is recognized—this is the only first-line treatment and delays in administration are associated with fatality. 1, 2
Immediate First-Line Treatment
Epinephrine is the cornerstone of anaphylaxis management and must never be delayed or substituted with antihistamines or bronchodilators. 1, 3
Epinephrine Administration
- Administer intramuscular epinephrine 0.01 mg/kg using 1:1000 concentration in the anterolateral thigh (maximum 0.3 mg in prepubertal children, 0.5 mg in adults) 4, 1, 2
- For children, use epinephrine auto-injector 0.15 mg if weight is 10-25 kg or 0.3 mg if ≥25 kg 1
- The intramuscular route in the lateral thigh is superior to other routes because it provides rapid absorption and higher epinephrine levels 5
- Repeat epinephrine every 5-15 minutes if symptoms persist or progress—there are no absolute contraindications to epinephrine in anaphylaxis 4, 1, 2
Immediate Supportive Measures
- Call emergency services (911/EMS) immediately 1
- Position patient supine with elevated lower extremities to prevent orthostatic hypotension and improve circulation to vital organs 4, 1
- If respiratory distress or vomiting is present, position patient for comfort 1
- Establish intravenous access and administer oxygen 6, 2
Subsequent Emergency Care (After Epinephrine)
Fluid Resuscitation
- Administer normal saline rapidly for volume replacement: 1-2 L in adults at 5-10 mL/kg in first 5 minutes; up to 30 mL/kg in first hour for children 4
- For graded responses: 500 mL for Grade II reactions, 1 L for Grade III reactions, escalating to 20-30 mL/kg for refractory cases 6, 2
- Up to 7 L of crystalloid may be necessary due to increased vascular permeability that can transfer 50% of intravascular fluid to extravascular space within 10 minutes 4
Airway Management
- Maintain airway patency—consider endotracheal intubation or cricothyroidotomy if laryngeal edema is severe and clinicians are adequately trained 4
- Administer supplemental oxygen, especially for prolonged reactions, pre-existing hypoxemia, or patients requiring multiple epinephrine doses 4
Second-Line Adjunctive Therapies (Never as Monotherapy)
Antihistamines
- Administer H1-antihistamine diphenhydramine 1-2 mg/kg or 25-50 mg parenterally only after epinephrine 4, 6, 2
- Consider H2-antihistamine ranitidine 50 mg IV in adults (1 mg/kg in children) diluted in 5% dextrose over 5 minutes 4, 6, 2
- The combination of H1 and H2 antihistamines is superior to H1 alone, but both have much slower onset than epinephrine 4
Bronchodilators
- For bronchospasm resistant to adequate epinephrine doses: administer nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as necessary 4, 2
Corticosteroids
- Consider systemic corticosteroids for patients with history of idiopathic anaphylaxis, asthma, or severe/prolonged anaphylaxis 4, 6
- Administer IV methylprednisolone equivalent 1.0-2.0 mg/kg/day every 6 hours, or oral prednisone 0.5 mg/kg for less critical episodes 4
- Corticosteroids are not helpful acutely but may prevent biphasic or protracted reactions 4, 2
Management of Refractory Anaphylaxis
Escalating Epinephrine
- If inadequate response after 10 minutes, double the epinephrine bolus dose 6
- Consider epinephrine infusion (0.05-0.1 μg/kg/min) when more than three boluses have been administered 6, 2
- Prepare infusion by adding 1 mg (1 mL) of 1:1000 epinephrine to 250 mL D5W (concentration 4.0 μg/mL), infuse at 1-4 μg/min, increasing to maximum 10 μg/min 4
Additional Vasopressors
- For hypotension refractory to epinephrine and fluids: add norepinephrine infusion (0.05-0.5 μg/kg/min) or dopamine 2-20 μg/kg/min titrated to maintain systolic BP >90 mmHg 4, 6, 2
- Consider vasopressin 1-2 IU bolus with or without infusion (2 units/h) for persistent hypotension 6
Special Considerations
- For patients on beta-blockers with refractory symptoms: administer IV glucagon 1-5 mg (20-30 μg/kg in children, maximum 1 mg) over 5 minutes, followed by infusion 5-15 μg/min 4, 6
- Glucagon bypasses beta-receptor blockade and has positive inotropic and chronotropic effects 4
Cardiopulmonary Arrest During Anaphylaxis
- Initiate CPR and advanced cardiac life support immediately 4, 2
- Administer high-dose IV epinephrine rapidly: 1-3 mg (1:10,000 dilution) over 3 minutes, then 3-5 mg over 3 minutes, followed by 4-10 μg/min infusion 4
- For children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution, maximum 0.3 mg) every 3-5 minutes 4
- Consider higher doses (0.1-0.2 mg/kg of 1:1000 solution) for unresponsive asystole or pulseless electrical activity 4
- Administer atropine and consider transcutaneous pacing for asystole/pulseless electrical activity 4
- Prolonged resuscitation efforts are encouraged—outcomes are better in anaphylaxis than other causes of arrest because patients are typically young with healthy cardiovascular systems 4
Critical Pitfalls to Avoid
- Never delay epinephrine administration—delayed injection is the primary factor associated with fatality 1, 3
- Never substitute antihistamines, corticosteroids, or bronchodilators for epinephrine—these are adjunctive only 1, 6, 2
- Never administer IV epinephrine in non-arrest situations without continuous hemodynamic monitoring due to risk of lethal arrhythmias 4
- IV epinephrine should only be used during cardiac arrest or in profoundly hypotensive patients who fail to respond to IM epinephrine and volume replacement 4, 2
Observation and Monitoring
- Observe all patients for minimum 6 hours in a monitored setting, as there are no reliable predictors of biphasic reactions 4, 1, 6
- Biphasic reactions (recurrence without re-exposure) can occur in up to 20% of cases 1
- Obtain serum tryptase levels if diagnosis is unclear: first sample at 1 hour, second at 2-4 hours, baseline at least 24 hours post-reaction 6
Post-Event Management
- Provide patient with two epinephrine auto-injectors and comprehensive training on self-administration 4, 1
- Provide written anaphylaxis emergency action plan detailing symptom recognition and treatment steps 1
- Refer all patients to an allergist-immunologist for diagnostic evaluation, identification of triggers, and long-term management 4, 1
- Consider medical identification jewelry 1